• Mithra and Searchlight Pharma announce Estelle® approval in Canada

    Monday March 8th 2021

  • Cardiology prepared for fourth dimension

    Friday March 5th 2021

  • Galapagos reports primary endpoint for the ongoing filgotinib MANTA and MANTA-RAy safety studies

    Thursday March 4th 2021

  • argenx announces FDA acceptance of BLA filing for Efgartigimod for the treatment of generalized myasthenia gravis

    Wednesday March 3rd 2021

  • Mithra and Farmitalia announce commercial launch of Myring™ in Italy

    Wednesday March 3rd 2021

  • Rejuvenate Biomed secures EUR 3.2 million series A round to advance development of healthy aging products

    Tuesday March 2nd 2021

  • European Centre for Disease Prevention and Control (ECDC) intensifies the identification and tracking of mutations of the SARSCoV-2 genome across Europe with support of Eurofins Genomics

    Friday February 26th 2021

  • AbolerIS Pharma strengthens management team to support next phases of growth

    Friday February 26th 2021

  • Your news here?

  • Sarcura and imec to collaborate on high throughput cytometry solution for automated (T-)cell separation

    Thursday February 25th 2021

  • Newton Biocapital invests in Flemish start-up DeuterOncology

    Wednesday February 24th 2021

  • Preventieve speekseltest voor het opsporen van het COVID-19 virus is nu beschikbaar voor bedrijven en organisaties

    Tuesday February 23rd 2021


Strategic Partners